DUAC

This brand name is authorized in Croatia, Estonia, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, New Zealand, Poland, Romania, Spain, UK.

Active ingredients

The drug DUAC contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII EH6D7113I8 - CLINDAMYCIN PHOSPHATE
 

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.

 
Read more about Clindamycin
2
UNII W9WZN9A0GM - BENZOYL PEROXIDE
 

Benzoyl peroxide is a highly lipophilic, oxidising agent with keratolytic and bacteriocidal effects. The effectiveness of benzoyl peroxide in the treatment of acne vulgaris is primarily attributable to its antibacterial activity, especially with respect to Propionibacterium acnes. Benzoyl peroxide is also believed to be effective in the treatment of acne on account of its anti-inflammatory and mild keratolytic properties.

 
Read more about Benzoyl peroxide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D10AF51 Clindamycin, combinations D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne
Discover more medicines within D10AF51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1155035, 1155046, 1155057, 1175723, 1175734, 1175947, 1175958, 1175969, 1539446
ES Centro de información online de medicamentos de la AEMPS 66679, 77733
GB Medicines & Healthcare Products Regulatory Agency 225544, 298560, 301781, 301783, 376314, 381299
HK Department of Health Drug Office 62215
HR Agencija za lijekove i medicinske proizvode HR-H-594265582
IE Health Products Regulatory Authority 22163, 22164, 36924
IL מִשְׂרַד הַבְּרִיאוּת 21016, 6589, 9119
JP 医薬品医療機器総合機構 2699803Q1020
LT Valstybinė vaistų kontrolės tarnyba 1016652, 1016653, 1016654, 1021552, 1021553, 1021554, 1021555, 1021556, 1061759, 1064231, 1072993, 1072994, 1074504
MT Medicines Authority MA192/02801
NZ Medicines and Medical Devices Safety Authority 11578
PL Rejestru Produktów Leczniczych 100132247, 100305883, 100420064
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W67839001, W67839002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.